Literature DB >> 2779168

Postmortem tricyclic antidepressant concentrations: assessing cause of death using parent drug to metabolite ratio.

F S Apple1.   

Abstract

In 9 of 13 medical examiner cases in which death was caused by tricyclic antidepressant (TCA) overdose, the mean postmortem liver and blood concentrations were 200 micrograms/g and 4.0 micrograms/mL, respectively. In comparison, in 4 of 13 cases in which the causes of death were not TCA related but involved therapeutic doses of TCA, the mean liver and blood levels were 29.0 micrograms/g and 1.3 micrograms/mL, respectively. The parent drug to major metabolite ratio in liver was 6.3:1 in overdose cases and 0.5:1 in therapeutic cases. The ratio in blood was greater than 1.0 in both overdose and therapeutic ingestions. We concluded that liver TCA concentrations should be quantitated to specify manner of death. For cases in which the manner of death was ambiguous, the liver parent drug to major metabolite ratio aided in the decision process.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2779168     DOI: 10.1093/jat/13.4.197

Source DB:  PubMed          Journal:  J Anal Toxicol        ISSN: 0146-4760            Impact factor:   3.367


  4 in total

1.  Estimating antemortem drug concentrations from postmortem blood samples: the influence of postmortem redistribution.

Authors:  D S Cook; R A Braithwaite; K A Hale
Journal:  J Clin Pathol       Date:  2000-04       Impact factor: 3.411

2.  Severe metformin intoxication with lactic acidosis in an adolescent.

Authors:  Martin Lacher; Maren Hermanns-Clausen; Karsten Haeffner; Matthias Brandis; Martin Pohl
Journal:  Eur J Pediatr       Date:  2005-02-24       Impact factor: 3.183

Review 3.  Sudden death related to selected tricyclic antidepressants in children: epidemiology, mechanisms and clinical implications.

Authors:  C K Varley
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

4.  Diffusion as a mechanism of postmortem drug redistribution: an experimental study in rats.

Authors:  T Hilberg; A Bugge; K M Beylich; J Mørland; A Bjørneboe
Journal:  Int J Legal Med       Date:  1992       Impact factor: 2.686

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.